Search
for
Sort by
Research 301–330 of 1000+
- COVID and Cancer: A Complete 3D Advanced Radiological CT-Based Analysis to Predict the Outcome
- Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
- Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- The role of sleep in telogen effluvium and trichodynia: A commentary in the context of the current pandemic
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ASSESSMENT OF THE RISK OF DEVELOPING ALOPECIA IN PATIENTS AFTER CORONAVIRAL INFECTIONAND EFFECTIVE TREATMENT METHODS
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
- Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID
- Association between genetically predicted leukocyte telomere length and non-scarring alopecia: A two-sample Mendelian randomization study
- Treatment of persistent chemotherapy-induced hair loss (Alopecia) with human mesenchymal stromal cells exosome enriched extracellular vesicles: A case report
- EVALUATION OF THE EFFICACY AND TOLERABILITY OF BIOTIN IN THE COMPLEX TREATMENT OF ANDROGENIC ALOPECIA
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Rehabilitation therapy for a severe case of coronavirus disease 2019: a case report